Simplifying Global Compliance
The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs / GMPs
DOJ Stressing Corporate Integrity Agreements to Maintain Compliance
Feb. 7, 2014
The Department of Justice (DOJ) wants to see that when it settles a fraud case with a drugmaker the company does not slip back to its old, bad habits once the prosecutors leave, and it’s increasingly using corporate integrity agreements to make that happen.
Drug Industry Daily
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing